David Blaisdell, BA

Quality Outlook

Oncology Quality Measurement: Angst and Ambition

09/18/2019

In the first installment of the Quality Outlook commentary series, Tom Valuck, MD, JD, Discern Health, part of Real Chemistry, and colleagues assert the need for value-based solutions and adequate value assessment measurements to ensure that...

In the first installment of the...

09/18/2019

Journal of Clinical Pathways

Quality Outlook

Measuring Adherence to Oral Anticancer Medications: A Persistent Problem

06/06/2024

Tom Valuck , MD, JD;

David Blaisdell , BA;

This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.

This blog post discusses the...

06/06/2024

Journal of Clinical Pathways

Quality Outlook

Catch Me If You Can: Aligning Quality Measurement With Oncology Innovation

11/22/2019

David Blaisdell , BA;

Tom Valuck , MD, JD;

Theresa Schmidt , MA, PMP, CSPO;

Tom Valuck, MD, JD, and colleagues of Discern Health, part of Real Chemistry, highlight the challenge that physicians face with integrating rapid science advances into practice while payers pressure them to improve value.

Tom Valuck, MD, JD, and...

11/22/2019

Journal of Clinical Pathways

Quality Outlook

We Need Better Quality Measures for Oncology Care First

01/24/2020

Manasi A. Tirodkar , PhD, MS;

David Blaisdell , BA;

Tom Valuck , MD, JD;

Tom Valuck, MD, JD, and colleagues of Discern Health, part of Real Chemistry, argue that if the Oncology Care First model proposed by CMS is adopted as proposed, CMS will be missing a critical opportunity to advance quality measurement for...

Tom Valuck, MD, JD, and...

01/24/2020

Journal of Clinical Pathways

Quality Outlook

Sound Check: Listening More Closely to Oncology Patients

03/24/2020

Manasi A. Tirodkar , PhD, MS;

David Blaisdell , BA;

Tom Valuck , MD, JD;

Theresa Schmidt , MA, PMP, CSPO;

Tom Valuck, MD, JD, and colleagues explore whether patient-reported measure sets and patient-reported performance measures truly represent oncology patients’ feedback and needs.

Tom Valuck, MD, JD, and...

03/24/2020

Journal of Clinical Pathways

Quality Outlook

Recognizing and Testing Telehealth Models in Oncology Care First

02/09/2021

David Blaisdell , BA;

Tom Valuck , MD, JD;

Theresa Schmidt , MA, PMP, CSPO;

In this blog, Tom Valuck, MD, JD, and colleagues explore ways for CMS to incorporate telehealth in oncology alternative payment models.

In this blog, Tom Valuck, MD,...

02/09/2021

Journal of Clinical Pathways

Quality Outlook

Telehealth Standards for Cancer Care: Better Safe Than Sorry

09/03/2021

David Blaisdell , BA;

Tom Valuck , MD, JD;

David Blaisdell discusses standards for telehealth and how these standards can be used to improve the safety and quality of digital cancer care.

David Blaisdell discusses...

09/03/2021

Journal of Clinical Pathways

Research Reports

Quality Measure Concepts to Fill Gaps in Assessing Oral Oncolytic Adherence: A Multistakeholder Measurement Strategy

06/16/2022

Sandra Kurtin , PhD;

Leigh Boehmer , PharmD;

Michael Reff , RPh, MBA;

Rachael Peroutky , MSPH;

David Blaisdell , BA;

Shelley Fuld Nasso , MPP;

Katie Schultz , MSPH;

Tom Valuck , MD, JD;

A multistakeholder workgroup of oncology and quality measurement experts explored gaps in quality measures focused on oral oncolytic adherence and identified, prioritized, and refined measure concepts for further development.

A multistakeholder workgroup of...

06/16/2022

Journal of Clinical Pathways

Quality Outlook

The Oncology-Oral Health Value Bridge: Put Your Money Where Your Mouth Is

08/18/2022

Nina Regenold , MSc;

Kaitlyn Esselman , MHS;

Eva Lenoir , MPH;

David Blaisdell , BA;

Tom Valuck , MD, JD;

Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...

Nina Regenold, MSc, and...

08/18/2022

Journal of Clinical Pathways

Research Reports

Measuring Telehealth Quality in Cancer Care: We Don’t Know What We Don’t Know

11/15/2022

Tom Valuck , MD, JD;

David Blaisdell , BA;

The authors evaluate key quality considerations related to the use of telehealth in oncology in the context of the National Committee for Quality Assurance and the National Quality Forum's recommendations and discuss strategies to enhance...

The authors evaluate key quality...

11/15/2022

Journal of Clinical Pathways